Nicotinamide Adenine Dinucleotide · Protocol Guide
NAD+: The Honest Longevity Guide
NAD+ is the most-marketed longevity therapy. The mechanism is real. The IV experience is real. The oral supplement bioavailability problem is real. This guide separates marketing from biology.
FDA Status
Off-Label, 503A Compounded
Pharmacy
Optimal Balance Pharmacy (503A licensed)
Medical Service
RxPepsDirect, physician-supervised
Access
33 U.S. States
Our promise: Oral NAD+ supplements have a bioavailability problem the marketing rarely admits. Injectable NAD+ has its own caveats including the flush. We walk through both honestly.
Medically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 18, 2026.Section 01
What NAD+ Actually Is
NAD+ (nicotinamide adenine dinucleotide) is not a peptide. It is a coenzyme present in every living cell, central to redox reactions, energy metabolism, DNA repair, and sirtuin signaling. NAD+ levels decline with age. The clinical hypothesis is that restoring NAD+ levels improves cellular function in tissues with declining metabolic capacity.
We include NAD+ in this peptide-protocol guide series because the same patients who pursue peptide therapy generally consider NAD+ supplementation, and the therapeutic format (compounded injectable from a 503A pharmacy) is identical. The biology is different. The access pathway is the same.
~50%
Estimated decline in tissue NAD+ between ages 30 and 60
2018
Year the Martens et al. NR trial demonstrated NAD+ elevation in older adults
0
Human RCTs demonstrating lifespan extension from NAD+ supplementation
Section 02
Who It Is Actually For
| Profile | Primary Goal | Fit |
|---|---|---|
| 40 to 65, energy decline, exercise tolerance loss | Cellular energy support, training recovery | Best Fit |
| Chronic illness recovery (post-COVID, ME/CFS) | Mitochondrial support adjunct to broader protocol | Strong Fit |
| Longevity biohacker | Sirtuin pathway support, DNA repair capacity | Moderate Fit |
| Heavy alcohol use or recent binge | NAD+ depletion via alcohol metabolism | Adjunct Only |
| Active cancer | N/A. NAD+ supports cellular proliferation pathways | Physician Decision Only |
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Profile
Primary Goal
Fit
Section 03
How It Works
NAD+ operates through three primary pathways: redox cofactor for mitochondrial electron transport (ATP production), substrate for sirtuin deacetylase enzymes (gene expression regulation), and substrate for PARP enzymes (DNA repair). All three are relevant to age-related decline.
Mitochondrial Redox
NAD+ shuttles electrons through the mitochondrial electron transport chain. Higher NAD+ availability supports more efficient ATP production, particularly in tissues with high energy demand (muscle, brain, heart).
Sirtuin Activation
SIRT1 through SIRT7 are NAD+ dependent enzymes that regulate gene expression, stress response, metabolic flexibility, and circadian rhythm. Sirtuin activity drops as NAD+ declines.
PARP and DNA Repair
PARP-1 uses NAD+ to repair DNA single-strand breaks. Chronic DNA damage consumes NAD+. Replenishing NAD+ supports ongoing repair capacity.
CD38 and Aging
CD38, an NAD+ consuming enzyme, increases with age and accelerates NAD+ decline. Restoring NAD+ levels partially offsets this loss.
Section 04
Realistic Expectations
NAD+ effects in well-responding patients are subtle and cumulative. Most users do not feel dramatic next-day changes. The strongest reported signals are improved morning energy, mental clarity, and exercise recovery developing over weeks.
Initial Response Window
Some patients report mental clarity and morning energy improvement within the first two weeks. Many notice nothing at this stage. NAD+ is not a stimulant.
Mitochondrial Adaptation
Exercise recovery improvements often appear in this window. Sleep quality improvements reported by some users. Skin quality changes (modest) appear in some patients.
Sustained Protocol Effect
The earliest window to assess overall response. Patients who respond well report durable energy and cognitive improvements. Non-responders show no meaningful change.
Section 05
IV vs Subcutaneous vs Oral
NAD+ delivery format is the most-debated topic in the longevity community. Each format has trade-offs in bioavailability, cost, convenience, and tolerability.
| Format | Bioavailability | Tolerability | Cost | Best For |
|---|---|---|---|---|
| IV Infusion (clinic) | Highest, immediate plasma elevation | Flush common | $300 to $800 per infusion | Acute recovery protocols, post-illness, intensive cycles |
| Subcutaneous Injection (RxPepsDirect) | Moderate, slower absorption window | Well-tolerated | $100 per 1000 mg vial | Sustained at-home protocol, cost-effective ongoing therapy |
| Oral NMN / NR Supplements | Indirect, raises NAD+ modestly | Excellent | $30 to $80 per month | Adjunct to other formats, baseline support |
| Intranasal NAD+ (RxPepsDirect) | Moderate, brain-targeted via olfactory nerve | Well-tolerated | Pharmacy-priced separately | Cognitive-focused protocols |
Format
Bioavailability
Tolerability
Cost
Best For
Format
Bioavailability
Tolerability
Cost
Best For
Format
Bioavailability
Tolerability
Cost
Best For
Format
Bioavailability
Tolerability
Cost
Best For
Section 06
Dosing Protocol
| Protocol | Dose | Frequency | Evidence Basis |
|---|---|---|---|
| RxPepsDirect Standard Subcutaneous | 20 mg (20 units) | Daily or 5 days per week | Clinical Practice |
| Loading Protocol | 50 to 100 mg | Daily for 2 weeks then reduce to maintenance | Community Anecdote |
| Maintenance Protocol | 20 to 50 mg | 3 to 5 days per week | Community Consensus |
Protocol
Dose
Frequency
Evidence Basis
Protocol
Dose
Frequency
Evidence Basis
Protocol
Dose
Frequency
Evidence Basis
Subcutaneous injection into abdominal fat using a standard insulin syringe (28 to 31 gauge, 6 to 8 mm needle). Rotate sites. Morning injection is preferred to align with natural energy demand. Mild local flushing at the injection site is common and resolves within 30 to 60 minutes.
Section 07
Ready to Inject
0
Reconstitution steps required
503A
Licensed pharmacy (Optimal Balance), physician-supervised
Overnight
FedEx shipping in a reusable cooled travel case
Section 08
Stacking
Pairs Well With
MOTS-c
Different pathway (AMPK vs sirtuin). Complementary mitochondrial support.
Sermorelin / Tesamorelin
GH-axis improvement plus cellular energy. Common longevity stack.
BPC-157
Tissue repair plus cellular energy. No mechanistic overlap.
Methylene Blue (low-dose)
Mitochondrial electron carrier. Some practitioners stack these in cognitive protocols.
Approach With Caution
Active cancer or recent cancer history
NAD+ supports cellular proliferation. Oncologist clearance required.
Chronic kidney disease
NAD+ metabolites are renally cleared. Physician oversight on dose required.
Pregnancy / lactation
No safety data. Avoid.
Methylation problems (MTHFR variants)
NAD+ metabolism intersects with methylation. Adjust methyl donor intake under physician guidance.
Section 09
Pricing
| Option | Medication Cost | Medical Cost | Notes |
|---|---|---|---|
| IV NAD+ Clinic Infusion | $300 to $800 per session | Clinic-bundled | Highest bioavailability, flush common, 2 to 4 hour appointment. |
| Other Online Clinics (injectable) | $200 to $400 per month | Visit fees often bundled | Per-cycle pricing varies. Verify all-in cost before committing. |
| Optimal Balance Pharmacy + RxPepsDirect | $100 per 1000 mg vial, paid to pharmacy | $39 visit fee, paid to RxPepsDirect | Pre-reconstituted subcutaneous, FedEx overnight, labeled to you. |
| Oral NMN / NR Supplements | $30 to $80 per month | None (OTC) | Lower bioavailability. Adjunct, not equivalent. |
Option
Medication Cost
Medical Cost
Notes
Option
Medication Cost
Medical Cost
Notes
Option
Medication Cost
Medical Cost
Notes
Option
Medication Cost
Medical Cost
Notes
Who You Pay, and What For
Pharmacy: Medication
$100 per 1000 mg vial. Compounded and shipped by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy.
Medical Service: Physician Consultation
$39 medical visit fee. Intake consultation including cancer-history screening, protocol design, prescription writing, and follow-up. Billed by RxPepsDirect for the medical service only.
Section 10
Legal Access in 33 States
503A Licensed Pharmacy
Optimal Balance Pharmacy, U.S. licensed
Physician Prescription Required
Compounded medication, Rx only
Off-Label, Legal Practice
Standard and legal in U.S. medicine
OTC Precursors Available
Oral NMN / NR supplements widely sold, separate category
Injectable NAD+ is available through 503A patient-specific compounding under physician prescription. Oral NAD+ precursors (NMN, NR) are broadly available as dietary supplements. The two are not interchangeable in bioavailability or regulatory status.
Section 11
Community Q&A
Why not just take NMN or NR orally?
Oral precursors raise NAD+ modestly in healthy adults, but the absolute increase per dollar spent is meaningfully lower than injectable. Use oral as an adjunct, not a substitute. If your goal is measurable NAD+ elevation, injectable is the format with the evidence.
What is the flush and how do I avoid it?
The flush is a rapid-infusion reaction: chest tightness, nausea, restlessness, sometimes muscle cramps. It scales with infusion rate. Subcutaneous injection releases NAD+ over a much longer window and largely avoids it. Clinic IV protocols deliver the infusion over 2 to 4 hours for the same reason.
Will NAD+ extend my lifespan?
No human RCT has demonstrated lifespan extension. The mechanistic case is plausible. The clinical data supports modest improvements in specific markers, not lifespan. Frame NAD+ as cellular energy and metabolic support, not as a proven longevity intervention.
Can I use NAD+ if I have a cancer history?
Active cancer is a contraindication. Recent cancer history requires oncologist clearance. NAD+ supports cellular proliferation pathways, which can theoretically benefit malignant as well as normal cells. RxPepsDirect screens for cancer history at intake.
What happens if Optimal Balance is out of stock?
Your RxPepsDirect physician will be notified and you will be contacted before any delay impacts your protocol. You only pay the pharmacy when your prescription actually ships.
Section 12
The RxPepsDirect Model
Pharmacy: Optimal Balance, 503A Licensed
Optimal Balance Pharmacy compounds your NAD+ under a patient-specific prescription, USP <797> sterile standards, and federal 503A oversight.
Medical Service: RxPepsDirect Physicians
A licensed physician reviews your history, screens for contraindications, designs your protocol, and writes your prescription. RxPepsDirect bills the $39 medical visit fee for this service.
Transparent Safety Communication
The guide flags the oral bioavailability caveat, the flush at high IV doses, the cancer contraindication, and the lack of lifespan-extension evidence. We do not hide limitations.
Legal Access in 33 States
Every shipment is a compounded prescription medication filled by a 503A licensed pharmacy under a physician prescription.
References
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014. PMID: 24786309
- Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018. PMID: 29249689
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PMID: 29599478
Related protocol guides
Other protocols in the same clinical territory. Each guide is co-bylined by a licensed RxPepsDirect prescriber.
Mitochondrial cognitive capsule (MB-5 to MB-25)
Methylene Blue guide: mitochondrial electron carrier, MAO-A inhibitor, the SSRI contraindication
Mitochondrial electron carrier at low dose, MAO-A inhibitor at any dose. SSRIs, SNRIs, MAOIs, TCAs are hard contraindications. Hormetic dose curve. Medication screening is mandatory.
Mitochondrial-derived peptide (metabolic)
MOTS-c protocol guide: AMPK activation, the WADA prohibition, and the human evidence gap
Strong rodent data, thin human RCT data. AMPK activator (different mechanism than metformin). WADA prohibited since 1/1/2025. Not an exercise substitute.
Mitochondria-targeted tetrapeptide
Elamipretide (SS-31) guide: cardiolipin-stabilizing mitochondria-targeted peptide
Cleanest mechanism in the mitochondrial-support category. Late-stage FDA program (Barth syndrome). Phase III ReCLAIM-2 missed primary endpoint. Available through 503A compounding.
Continue reading